Invesaro

Stocks SLAIY Financial statements

Financial statements

SOLAI Ltd financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data SOLAI Ltd files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue1.5720.218.35.162.1753.85743.132.923
Cost of revenue2.048.1611.67.661.7924.83529.118.623.7
Gross profit-0.46126.7-2.50.3829221414.3-0.72
Research and development10.310.592.861.941.262.210.870.07
Selling and marketing6.4711.813.43.031.150.890.340.150.050.05
General and administrative35.739.536.618.714.322.321.918.513.718.3
Operating expenses24.617.429.624.519.513.818.3
Operating income-52.8-53.9-50.1-74-17-44.3-89.6-25.2-8.01-34.7
Interest expense000.780.22
Interest income3.443.162.231.310.240.060.150.240.060.15
Pre-tax income-29.7-50.5-71.5-75.9-23.4-39.9-79.4-25.4-7.01-34.5
Income tax0.44-1.9-2.85-1.08-0.03-0.360000
Income from continuing operations27.7-76.4-25.4-6.85-33.9
Net income to minority interests-0.910.15
Net income-29.2-48.7-65.7-94.4-32.4-62.4-155-28.712.1-33.9
EBITDA-50.9-47.9-41-65.1-9.97-29.3-65.6-15.32.14-22.4
EPS, basic-0.07-0.12-0.16-0.22-0.07-0.10-0.18-0.030.01-0.02
EPS, diluted-0.07-0.12-0.16-0.22-0.07-0.10-0.18-0.030.01-0.02
Shares, basic (weighted)4154084194294306228711,1021,1721,727
Shares, diluted (weighted)4154084194294306228711,1021,1721,727

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents10381.363.351.947.317.75.53.241.811.42
Short-term investments14.418.414.52.36000
Receivables0.743.582.881.852.76
Other current assets2.711.949.484.351.5621.58.226.35.916.52
Total current assets24611387.561.851.593.335.333.919.117.7
Property, plant and equipment7.7716.414.19.21170.227.222.819.912.2
Lease right-of-use assets5.261.436.174.144.272.631.99
Goodwill23.14018.926.600
Intangible assets44.744.731.30.650.2471.93.32.0311.15.86
Long-term investments12.353.328.32214.110.18.054.173.563.4
Other non-current assets0.390.960.520.270.094.460.060.060.02
Total assets29927018199.972.129486.872.686.345.6
Accounts payable54.43.670.820.030.57
Accrued liabilities2.342.561.420.990.170.490.750.410.310.32
Total current liabilities30.22714.511.111.384.430.844.911.210
Long-term debt6.414.270.610.430.08
Lease liabilities4.550.894.572.842.541.060.86
Other non-current liabilities7.26
Total liabilities38.734.316.216.112.38933.747.519.610.9
Total debt6.414.270.610.430.08
Paid-in capital317353354366412591621622641652
Retained earnings-77.5-132-190-282-324-387-542-571-558-592
Treasury stock-17.8-22.1-20.9-20.7-21.6-21.6-21.6-21.6-21.6-21.6
Other comprehensive income24.917.82020.3-4.6-2.36-3.96-4.28-4.39-4.25
Shareholders' equity2462171628461.818053.125.156.934.2
Minority interests14.215.3-1.61-2.21-1.9825.49.890.5
Total equity26023216181.759.920553.125.166.834.7
Total liabilities and equity29927018199.972.129486.872.686.345.6

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income-30.1-48.6-66.8-94.9-32.1-74.4-158-28.711.9-34.5
Depreciation and amortization1.856.079.18.827.0215.124.19.8610.112.3
Stock-based compensation23.51415.811.58.056.454.471.031.210.85
Deferred income tax-0.070.06-0.05-1.11-0.03-0.36
Change in receivables-0.630001.68-3.8-2.591.28-0.92
Change in payables0000-7.7
Cash from operations-16.5-31.1-23.3-22.3-9.81-34.3-63.6-28.4-32.7-26.9
Capital expenditures-3.87-11.2-5.18-0.54-0.23-56.6-13.8-1.43-1.18-0.22
Acquisitions-0.96-57.500-21.9
Purchases of investments-30.7-3.0700-12.3-1-2.36
Cash from investing72.616.7-1.389.63.33-75.424.426.228.915.9
Stock issued1.810.866.032.46652.3410.6
Share buybacks-18.9-2.66
Cash from financing-16.9-1.427.972.46077.729.82.3710.7
Exchange rate effect0.01-6.293.090.061.821.92-2.83-0.050.06-0.07
Net change in cash39.2-22.1-13.7-10.1-4.65-30.1-12.2-2.3-1.47-0.39
Free cash flow-20.3-42.3-28.5-22.8-10-90.9-77.3-29.8-33.9-27.1
Income taxes paid0.011.370000

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $0.12 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin-3.1%Gross profit / revenue.
Operating margin-150.9%Operating income / revenue.
EBITDA margin-97.3%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-149.9%Pre-tax income / revenue.
Net margin-147.3%Net income / revenue.
FCF margin-118.0%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin-117.1%Cash from operations / revenue.
Return on equity (ROE)-74.4%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-51.4%Net income / average total assets.
Return on invested capital (ROIC)-62.4%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue3.7%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue1.0%Capital expenditures / revenue.
D&A / revenue53.5%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y-30.1%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-26.1%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y60.4%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y-105.0%Gross profit vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y-1,145.0%EBITDA vs the same period a year earlier. Only from a positive base.
Net income growth, 1y-380.6%Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y-300.0%EPS vs the same period a year earlier. Only from a positive base.
Book value growth, 1y-39.8%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-13.6%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y-11.2%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y-47.2%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-19.3%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-8.8%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y47.4%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y25.6%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y32.1%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.76xCurrent assets / current liabilities.
Quick ratio0.42x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.14x(Cash + short-term investments) / current liabilities.
Liabilities / assets23.9%Total liabilities / total assets.
Working capital$7.7MCurrent assets - current liabilities.
Goodwill and intangibles / assets12.9%(Goodwill + intangible assets) / total assets.
Tangible book value$28.4MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.35xRevenue / average total assets.
Fixed asset turnover1.43xRevenue / average property, plant and equipment.
Receivables turnover9.99xRevenue / average receivables.
Days sales outstanding37 days365 x average receivables / revenue.
Days payables5 days365 x average accounts payable / cost of revenue.

Per share

MetricValueHow it is calculated
EPS, diluted-$0.02Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic-$0.02Net income per basic share, as reported (split-adjusted).
Revenue per share$0.01Revenue / diluted weighted shares.
FCF per share-$0.02Free cash flow / diluted weighted shares.
Operating cash flow per share-$0.02Cash from operations / diluted weighted shares.
Book value per share$0.02Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$0.02Tangible book value / shares outstanding.
Cash per share$0.00(Cash + short-term investments) / shares outstanding.
What was SOLAI Ltd's revenue in fiscal 2025?

SOLAI Ltd reported revenue of $23.0M for fiscal 2025, 30.1% lower than the year before.

Was SOLAI Ltd profitable in fiscal 2025?

No. It reported a net loss of $33.9M.

How much free cash flow did SOLAI Ltd generate in fiscal 2025?

Cash from operations of $26.9M minus capital expenditures of $220.0K left free cash flow of -$27.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to SOLAI Ltd